Bayer Pharma News Today

What we have seen a few days ago. Aude up by over 1 despite cut in the outlook for global oil demand, yet still see i still seeing some kind of rally in place. We bring you this mornings market moving news from all around the world. Joining us is bloombergs enda leon, emmanando good chandra, and michael mckee. Walk us through what we learned from the inflation front. Enda we had refractory data that should inflation in threed, the first years. It suggests factories in china are heading into defl...

China. Xi jinping ahead of talks with President Trump before the g20. Bayer shares jump as the German Chemicals group bolsters its legal team to address a multibillion dollar litigation challenge around its roundup we weed killer. And h m reports sales of its summer collection are off to a strong start with the firms shares on course for their best day in three months. Good morning a bit of italian data this morning. Italy june Consumer Confidence numbers are just out theyve fallen to 109. 6 ver...

NOTICE OF MEETING AND MANAGEMENT PROXY CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS ...

Momentum in funding raised by private equity (PE) and venture capital (VC) picked up further this week, mainly propelled by a couple of big-ticket transactions ......

Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited (BZPPL), established in 2011 for pharmaceutical sales and marketing in India. Bayer is now acquiring full ownership of the entity as per pre-agreed terms. The joint venture successfully combined Zyduss Indian marketing expertise and distribution network with Bayers global innovation, making strides in various therapeutic areas.

PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) and Compugen (NASDAQ:CGEN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation. Profitability This table compares PharmaCyte Biotech and Compugen’s […]

/PRNewswire/ -- Life Molecular Imaging (LMI) and SOFIE Biosciences (SOFIE), a national US manufacturer and developer of PET radiopharmaceuticals, announce that...

The Middle East’s Veterinary Vaccine Industry is on the verge of remarkable expansion, projected to maintain a strong 4% Compound Annual Growth Rate (CAGR) until 2033. The demand outlook for veterinary vaccines in the Middle East is exceptionally positive, with an estimated market size of US$ 627.1 million in 2023.T...

/PRNewswire/ -- CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic Neuraceq® (florbetaben 18F injection) has...

Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance the function of Regulatory T Cells , today announced its financial...